Bladder cancer urine. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Urinary Bladder Urine Urothelium Cell Line, Tumor Tumor Cells, Cultured Urethra Chromosomes, Human, Pair 9 Neoplastic Stem Cells Prostate Urinary Reservoirs, Continent Urinary Tract Pelvis Mucous Membrane Muscle, Smooth Nails

Organisms5

Mice, Nude Adenoviridae Mice, Inbred BALB C Mice, SCID Rats, Inbred F344

Diseases54

Urinary Bladder Neoplasms Carcinoma, Transitional Cell Urinary Bladder Diseases Neoplasm Invasiveness Urinary Bladder, Overactive Urinary Bladder Calculi Urinary Bladder, Neurogenic Urinary Bladder Neck Obstruction Prostatic Neoplasms Neoplasm Recurrence, Local Disease Progression Carcinoma Lung Neoplasms Genetic Predisposition to Disease Cystitis Hematuria Neoplasms Muscle Neoplasms Neoplasm Metastasis Breast Neoplasms Ovarian Neoplasms Stomach Neoplasms Colonic Neoplasms Bladder Exstrophy Carcinoma, Squamous Cell Pancreatic Neoplasms Carcinoma in Situ Urethral Neoplasms Urologic Neoplasms Cell Transformation, Neoplastic Uterine Cervical Neoplasms Occupational Diseases Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Neovascularization, Pathologic Disease Models, Animal Rectal Neoplasms Arsenic Poisoning Cystitis, Interstitial Adenocarcinoma Neoplasms, Second Primary Precancerous Conditions Esophageal Neoplasms Schistosomiasis Gallbladder Neoplasms Kidney Neoplasms Endometrial Neoplasms Neoplasms, Experimental Cocarcinogenesis Liver Neoplasms Urologic Diseases Urogenital Neoplasms Neoplasms, Multiple Primary Dysuria

Chemicals and Drugs52

Tumor Markers, Biological Benzidines Aminobiphenyl Compounds Neoplasm Proteins Antineoplastic Agents Arylamine N-Acetyltransferase RNA, Messenger BCG Vaccine Butylhydroxybutylnitrosamine DNA, Neoplasm Carcinogens Cisplatin Cancer Vaccines Hair Dyes Tumor Suppressor Protein p53 Receptor, Fibroblast Growth Factor, Type 3 RNA, Small Interfering Antigens, Neoplasm Arsenic Tumor Suppressor Proteins Mitomycin Deoxycytidine Receptor, erbB-2 MicroRNAs Antineoplastic Agents, Phytogenic Toluidines Glutathione Transferase FANFT Receptors, Estrogen Anticarcinogenic Agents Receptor, Epidermal Growth Factor Prostate-Specific Antigen Carcinogens, Environmental Nuclear Proteins Rubber DNA-Binding Proteins Fluorouracil Inhibitor of Apoptosis Proteins RNA, Neoplasm Antibiotics, Antineoplastic Paclitaxel Antibodies, Monoclonal Antimetabolites, Antineoplastic Amines Tamoxifen Vinblastine Biological Markers Uroplakin II Transcription Factors DNA Primers 2-Naphthylamine Proto-Oncogene Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Administration, Intravesical Cystectomy Cystoscopy Early Detection of Cancer Neoplasm Staging Prognosis Urinary Diversion Risk Factors Survival Analysis Risk Reverse Transcriptase Polymerase Chain Reaction Retrospective Studies Follow-Up Studies Survival Rate Case-Control Studies Urinalysis Gene Expression Profiling Immunohistochemistry Prospective Studies Sensitivity and Specificity Xenograft Model Antitumor Assays Risk Assessment Antineoplastic Combined Chemotherapy Protocols Odds Ratio Disease-Free Survival Polymerase Chain Reaction Blotting, Western Neoplasm Transplantation Neoplasm Grading Combined Modality Therapy Treatment Outcome Chemotherapy, Adjuvant Registries Multivariate Analysis Incidence Oligonucleotide Array Sequence Analysis Kaplan-Meier Estimate Predictive Value of Tests Drug Screening Assays, Antitumor Transplantation, Heterologous Cohort Studies Reproducibility of Results SEER Program Disease Models, Animal Transfection Questionnaires Immunotherapy Confidence Intervals Logistic Models Immunoenzyme Techniques Urologic Surgical Procedures In Situ Hybridization, Fluorescence Biopsy Clinical Trials as Topic Ureterostomy Flow Cytometry Tissue Array Analysis Genetic Therapy Urinary Catheterization Urinary Reservoirs, Continent Tumor Burden Real-Time Polymerase Chain Reaction Organ Sparing Treatments Models, Biological DNA Mutational Analysis Diagnostic Techniques, Urological Molecular Targeted Therapy Neoplasms, Experimental Drug Administration Schedule Gene Knockdown Techniques Urine Specimen Collection Reference Values Radiotherapy Chromatography, High Pressure Liquid

Psychiatry and Psychology1

Phenomena and Processes42

Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Risk Urination Genotype Sensitivity and Specificity Polymorphism, Genetic Cell Proliferation Odds Ratio DNA Methylation Drug Resistance, Neoplasm Apoptosis Mutation Time Factors Dose-Response Relationship, Drug Genes, p53 Cell Survival Down-Regulation Cell Movement Cell Division Cell Cycle Genes, Tumor Suppressor Urodynamics Cell Growth Processes Phenotype Chromosomes, Human, Pair 9 Transfection Promoter Regions, Genetic Base Sequence RNA Interference Diet Signal Transduction Gene Expression Up-Regulation Genes, Neoplasm Gene Silencing Loss of Heterozygosity Alleles Drug Synergism DNA Repair Gene Amplification Epithelial-Mesenchymal Transition

Disciplines and Occupations3

Immunohistochemistry Urology Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Technology, Industry, Agriculture2

Rubber Chemical Industry

Information Science7

Survival Rate Registries Incidence SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups2

Survivors Asian Continental Ancestry Group

Health Care30

Risk Factors Survival Analysis Risk Retrospective Studies Follow-Up Studies Survival Rate Case-Control Studies Prospective Studies Sensitivity and Specificity Risk Assessment Odds Ratio Disease-Free Survival Treatment Outcome Registries Multivariate Analysis Occupational Exposure Age Factors Incidence Kaplan-Meier Estimate Predictive Value of Tests Cohort Studies Environmental Exposure Reproducibility of Results National Cancer Institute (U.S.)SEER Program Questionnaires Confidence Intervals Logistic Models Clinical Trials as Topic Sex Factors

Geographicals6

New Hampshire United States Egypt China Japan Maine

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Urinary Bladder Neoplasms Urinary Bladder Urine Carcinoma, Transitional Cell Administration, Intravesical Cystectomy Cystoscopy Urinary Bladder Diseases Urothelium Neoplasm Invasiveness Urinary Bladder, Overactive Early Detection of Cancer Tumor Markers, Biological Urinary Bladder Calculi Urinary Bladder, Neurogenic Gene Expression Regulation, Neoplastic Cell Line, Tumor Neoplasm Staging Urinary Bladder Neck Obstruction Prognosis Benzidines Urinary Diversion Prostatic Neoplasms Smoking Neoplasm Recurrence, Local Aminobiphenyl Compounds Disease Progression Mice, Nude Carcinoma Lung Neoplasms Genetic Predisposition to Disease Cystitis Neoplasm Proteins Hematuria Antineoplastic Agents Risk Factors Neoplasms Arylamine N-Acetyltransferase Survival Analysis New Hampshire Muscle Neoplasms Neoplasm Metastasis Risk Breast Neoplasms Ovarian Neoplasms Urination Reverse Transcriptase Polymerase Chain Reaction Retrospective Studies RNA, Messenger Follow-Up Studies Survival Rate Stomach Neoplasms Case-Control Studies Urinalysis BCG Vaccine Colonic Neoplasms Butylhydroxybutylnitrosamine DNA, Neoplasm Gene Expression Profiling Bladder Exstrophy Immunohistochemistry Tumor Cells, Cultured Genotype Prospective Studies Carcinogens Sensitivity and Specificity Cisplatin Xenograft Model Antitumor Assays Polymorphism, Genetic Risk Assessment Cancer Vaccines Cell Proliferation Antineoplastic Combined Chemotherapy Protocols Odds Ratio Disease-Free Survival Hair Dyes Carcinoma, Squamous Cell Polymerase Chain Reaction DNA Methylation Pancreatic Neoplasms Blotting, Western Tumor Suppressor Protein p53 Neoplasm Transplantation Drug Resistance, Neoplasm Neoplasm Grading Apoptosis Mutation Combined Modality Therapy Treatment Outcome Receptor, Fibroblast Growth Factor, Type 3 Time Factors Carcinoma in Situ Urethral Neoplasms Chemotherapy, Adjuvant United States Dose-Response Relationship, Drug Registries Multivariate Analysis Genes, p53 RNA, Small Interfering

No FAQ available that match "bladder cancer urine"